Pancreatic cancer, radiomics and artificial intelligence
Open accessThe DOI matches its Crossref record; 12 of the 12 references it cites were found in a registry or an index.
Abstract
Patients with pancreatic ductal adenocarcinoma (PDAC) are generally classified into four categories based on contrast-enhanced CT at diagnosis: resectable, borderline resectable, unresectable, and metastatic disease. In the initial grading and staging of PDAC, structured radiological templates are useful but limited, as there is a need to define the aggressiveness and microscopic disease stage of these tumours to ensure adequate treatment allocation. Quantitative imaging analysis allows radiomics and dynamic imaging features to provide information of clinical outcomes, and to construct clinical models based on radiomics signatures or imaging phenotypes. These quantitative features may be used as prognostic and predictive biomarkers in clinical decision-making, enabling personalised management of advanced PDAC. Deep learning and convolutional neural networks also provide high level bioinformatics tools that can help define features associated with a given aspect of PDAC biology and aggressiveness, paving the way to define outcomes based on these features. Thus, the prediction of tumour phenotype, treatment response and patient prognosis may be feasible by using such comprehensive and integrated radiomics models. Despite these promising results, quantitative imaging is not ready for clinical implementation in PDAC. Limitations include the instability of metrics and lack of external validation. Large properly annotated datasets, including relevant semantic features (demographics, blood markers, genomics), image harmonisation, robust radiomics analysis, clinically significant tasks as outputs, comparisons with gold-standards (such as TNM or pretreatment classifications) and fully independent validation cohorts, will be required for the development of trustworthy radiomics and artificial intelligence solutions to predict PDAC aggressiveness in a clinical setting.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
nnU-Net: a self-configuring method for deep learning-based biomedical image segmentation
Isensee, F., Jaeger, P. F., Kohl, S. A. A., Petersen, J., & Maier-Hein, K. H. (2021) · Nature Methods · doi:10.1038/s41592-020-01008-z · Cited by 10,477
Radiomics: the bridge between medical imaging and personalized medicine
Lambin, P., Leijenaar, R. T. H., Deist, T. M., Peerlings, J., de Jong, E. E. C., van Timmeren, J., Sanduleanu, S., Larue, R. T. H. M., Even, A. J. G., Jochems, A., et al. (2017) · Nature Reviews Clinical Oncology · doi:10.1038/nrclinonc.2017.141 · Cited by 5,688
Zwanenburg, A., Vallières, M., Abdalah, M. A., Aerts, H. J. W. L., Andrearczyk, V., Apte, A., Ashrafinia, S., Bakas, S., Beukinga, R. J., Boellaard, R., et al. (2020) · Radiology · doi:10.1148/radiol.2020191145 · Cited by 4,177
Oncogenic Signaling Pathways in The Cancer Genome Atlas
Sanchez-Vega, F., Mina, M., Armenia, J., Chatila, W. K., Luna, A., La, K. C., Dimitriadoy, S., Liu, D. L., Kantheti, H. S., Saghafinia, S., et al. (2018) · Cell · doi:10.1016/j.cell.2018.03.035 · Cited by 3,201
The Biological Meaning of Radiomic Features
Tomaszewski, M. R., & Gillies, R. J. (2021) · Radiology · doi:10.1148/radiol.2021219005 · Cited by 327
Chu, L. C., Park, S., Kawamoto, S., Fouladi, D. F., Shayesteh, S., Zinreich, E. S., Graves, J. S., Horton, K. M., Hruban, R. H., Yuille, A. L., et al. (2019) · American Journal of Roentgenology · doi:10.2214/ajr.18.20901 · Cited by 193
Nasief, H., Zheng, C., Schott, D., Hall, W., Tsai, S., Erickson, B., & Allen Li, X. (2019) · npj Precision Oncology · doi:10.1038/s41698-019-0096-z · Cited by 181
Kaissis, G., Ziegelmayer, S., Lohöfer, F., Algül, H., Eiber, M., Weichert, W., Schmid, R., Friess, H., Rummeny, E., Ankerst, D., et al. (2019) · European Radiology Experimental · doi:10.1186/s41747-019-0119-0 · Cited by 79
Yamashita, R., Perrin, T., Chakraborty, J., Chou, J. F., Horvat, N., Koszalka, M. A., Midya, A., Gonen, M., Allen, P., Jarnagin, W. R., et al. (2020) · European Radiology · doi:10.1007/s00330-019-06381-8 · Cited by 76
Zhang, Y., Lobo-Mueller, E. M., Karanicolas, P., Gallinger, S., Haider, M. A., & Khalvati, F. (2021) · Scientific Reports · doi:10.1038/s41598-021-80998-y · Cited by 62
Cited by
Yao, L., Zhang, Z., Keles, E., Yazici, C., Tirkes, T., & Bagci, U. (2023) · Current Opinion in Gastroenterology · doi:10.1097/mog.0000000000000966 · Cited by 53
A bibliometric analysis of the advance of artificial intelligence in medicine
Lin, M., Lin, L., Lin, L., Lin, Z., & Yan, X. (2025) · Frontiers in Medicine · doi:10.3389/fmed.2025.1504428 · Cited by 36
“This bibliometric study aids researchers in identifying the present state and developing trends in medical AI and is beneficial for optimizing medical resource use and enhancing patients’ quality of life.”
Pancreatic Adenocarcinoma: Imaging Modalities and the Role of Artificial Intelligence
Anghel, C., Mugur, G. C., Anghel, D. A., Rusu-Munteanu, G. I., Dumitru, R. L., & Lupescu, I. G. (2024) · doi:10.20944/preprints202401.0904.v1 · Cited by 23
Zhao, B., Cao, B., Xia, T., Zhu, L., Yu, Y., Lu, C., Tang, T., Wang, Y., & Ju, S. (2025) · Journal of Magnetic Resonance Imaging · doi:10.1002/jmri.29708 · Cited by 9
Metadata
- Authors
- Marti-Bonmati, L., Cerdá-Alberich, L., Pérez-Girbés, A., Díaz Beveridge, R., Montalvá Orón, E., Pérez Rojas, J., & Alberich-Bayarri, A.
- Venue
- The British Journal of Radiology
- Publisher
- Oxford University Press (OUP)
- Published
- 2022-09-01
- Volume
- 95
- Issue
- 1137
- Pages
- 20220072-20220072
- ISSN
- 0007-1285 (ISSN-L)
- 1748-880X
- OpenAlex
- W4281876958
- Cited by
- 41
- References
- 12
- FWCI
- 4.63
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Pancreatic cancer, radiomics and artificial intelligence. https://app.cochat.ai/papers/10.1259/bjr.20220072
- The paper
- Marti-Bonmati, L., Cerdá-Alberich, L., Pérez-Girbés, A., Díaz Beveridge, R., Montalvá Orón, E., Pérez Rojas, J., & Alberich-Bayarri, A. (2022). Pancreatic cancer, radiomics and artificial intelligence. The British Journal of Radiology. https://doi.org/10.1259/bjr.20220072
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.